Summary Probuphine is the first subdermal implant for the maintenance treatment of opioid use disorder designed to provide continuous, non-fluctuating, blood levels of buprenorphine for up to six...

Summary Vivitrol is an extended-release injectable formulation of naltrexone, administered as an intramuscular injection once a month. Naltrexone is an opioid-receptor antagonist that blocks the...